You are here
Rare Disease Pipeline
and Clinical Trials
An Unwavering Commitment to Patients and Ethical Research
Pfizer's mission is to deliver medicines that make a real difference in quality of life for patients with rare disease. Scientists in our research and development (R&D) programs are committed to speeding the delivery of new treatments. We pledge to maintain the safety of patients who take part in our trials and to uphold the highest ethical standards in all of our research initiatives.
On this page, you will find more information about our pipeline, which investigational therapies are under development, and in which stages. Search here to learn more about clinical trials in your area and for the investigational therapies in which you are most interested.
Blocks after Body
Rare Disease product pipeline
Pipeline date and pdf
Rare Disease Pipeline as of August 2, 2016
Master Pipeline Phase Count
- Discovery Projects